SEC Comment Letter for HAWTHORN BANCSHARES, INC. (HWBK) (CIK 0000893847) (HWBK) — Oct 13, 2005
HAWTHORN BANCSHARES, INC. (HWBK) (CIK 0000893847)
Date: Oct. 13, 2005 · CIK: 0000893847 · Accession: 0000000000-05-052477
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 000-23636
Referenced dates: September 16, 2005
Letter
October 11, 2005 Mail Stop 4561 By U.S. Mail and facsimile to (573) 761-6272 Mr. James E. Smith Chief Executive Officer Exchange National Bancshares, Inc. 132 East High Street Jefferson City, MO 65101
Re: Exchange National Bancshares, Inc Form 10-K for Fiscal Year Ended December 31, 2004 File No. 000-23636
Dear Mr. Smith:
We have reviewed your response letter dated September 16, and have the following additional comment.
Form 10-K
Exhibit 13
2004 Annual Report to Shareholders
Management`s Discussion and Analysis of Financial Condition and Results of Operations
Allocation of the Allowance for Loan Losses, page 21
1. Please refer to prior comment #1. Your reserve allocation worksheets for 2003 and 2004 showed widely differing loss percentages. Loss percentages for your substandard loans with specific allocations were so large as to suggest that some or all of those loans were impaired. Please tell us:
* your rationale for categorizing the loans as "substandard" verses "impaired" given the significant allowance to loan balance ratios, and
* how you applied SFAS 114 paragraphs 12-16 and SFAS 118 paragraph in your impaired loan disclosures.
* * * *
Please respond to this comment within 10 business days or tell us when you will provide us with a response. Please furnish a letter that keys your responses to our comment and provide any requested supplemental information. Detailed letters greatly facilitate our review. Please understand that we may have additional comments after reviewing your response to our comments.
You may contact Paula Smith (Staff Accountant) at (202) 551- 3696 or me at (202) 551-3490 if you have any questions regarding comments on the financial statements and related matters.
Sincerely,
Don Walker
Senior Assistant Chief
Accountant
??
Show Raw Text
<DOCUMENT>
<TYPE>LETTER
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
October 11, 2005
Mail Stop 4561
By U.S. Mail and facsimile to (573) 761-6272
Mr. James E. Smith
Chief Executive Officer
Exchange National Bancshares, Inc.
132 East High Street
Jefferson City, MO 65101
Re: Exchange National Bancshares, Inc
Form 10-K for Fiscal Year Ended December 31, 2004
File No. 000-23636
Dear Mr. Smith:
We have reviewed your response letter dated September 16,
2005
and have the following additional comment.
Form 10-K
Exhibit 13
2004 Annual Report to Shareholders
Management`s Discussion and Analysis of Financial Condition and
Results of Operations
Allocation of the Allowance for Loan Losses, page 21
1. Please refer to prior comment #1. Your reserve allocation
worksheets for 2003 and 2004 showed widely differing loss
percentages. Loss percentages for your substandard loans with
specific allocations were so large as to suggest that some or all
of
those loans were impaired.
Please tell us:
* your rationale for categorizing the loans as "substandard"
verses
"impaired" given the significant allowance to loan balance ratios,
and
* how you applied SFAS 114 paragraphs 12-16 and SFAS 118 paragraph
6
in your impaired loan disclosures.
* * * *
Please respond to this comment within 10 business days or
tell
us when you will provide us with a response. Please furnish a
letter
that keys your responses to our comment and provide any requested
supplemental information. Detailed letters greatly facilitate our
review. Please understand that we may have additional comments
after
reviewing your response to our comments.
You may contact Paula Smith (Staff Accountant) at (202)
551-
3696 or me at (202) 551-3490 if you have any questions regarding
comments on the financial statements and related matters.
Sincerely,
Don Walker
Senior Assistant Chief
Accountant
??
??
??
??
James E. Smith, Chief Executive Officer
Exchange National Bancshares, Inc.
Page 1 of 2
</TEXT>
</DOCUMENT>